-transparent.png){kind=logo}
Mice can be protected against the toxicity arising from lethal doses of methotrexate with purine and pyrimidine combinations, but not with pyrimidine alone. Furthermore, methotrexate treatment of tumour-bearing mice, conjunction with purine/pyrimidine protection, can be more effective than conventional metotrexate/folinic acid treatment.
Related Publications
K R Harrap, and
G A Taylor, and
G P Browman
December 1979,
Meditsinskaia radiologiia,
K R Harrap, and
G A Taylor, and
G P Browman
July 1968,
Archives of biochemistry and biophysics,
K R Harrap, and
G A Taylor, and
G P Browman
January 1971,
Lancet (London, England),
K R Harrap, and
G A Taylor, and
G P Browman
December 1953,
Archives of biochemistry and biophysics,
K R Harrap, and
G A Taylor, and
G P Browman
June 1953,
Federation proceedings,
K R Harrap, and
G A Taylor, and
G P Browman
January 1956,
Annual review of biochemistry,
K R Harrap, and
G A Taylor, and
G P Browman
January 2014,
Handbook of clinical neurology,
K R Harrap, and
G A Taylor, and
G P Browman
September 1950,
Nature,
K R Harrap, and
G A Taylor, and
G P Browman
January 1951,
Annual review of biochemistry,
K R Harrap, and
G A Taylor, and
G P Browman
January 1950,
Annual review of biochemistry,
